Treatment with high-dose simvastatin reduces secretion of apolipoprotein B-lipoproteins in patients with diabetic dyslipidemia (Q46703453)

24 December 2017

title

Treatment with high-dose simvastatin reduces secretion of apolipoprotein B-lipoproteins in patients with diabetic dyslipidemia (English)

1 reference

24 December 2017

1 reference

1 reference

1 reference

6

1 reference

24 December 2017

author name string

Merle Myerson

1

1 reference

24 December 2017

Colleen Ngai

2

1 reference

24 December 2017

Jeffrey Jones

3

1 reference

24 December 2017

Steve Holleran

4

1 reference

24 December 2017

Rajasekhar Ramakrishnan

5

1 reference

24 December 2017

Henry N Ginsberg

7

1 reference

24 December 2017

publication date

14 September 2005

1 reference

24 December 2017

Journal of Lipid Research

published in

1 reference

24 December 2017

volume

46

1 reference

24 December 2017

page(s)

2735-2744

1 reference

24 December 2017

issue

12

1 reference

24 December 2017

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel

cites work

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Insulin resistance and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Comparison of statins in hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Effects of statins on triglyceride metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Effect of atorvastatin on apolipoprotein B100 containing lipoprotein metabolism in type-2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Effect of somatostatin-induced suppression of postprandial insulin response upon the hypertriglyceridemia associated with a high carbohydrate diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Transport of Very Low Density Lipoprotein Triglycerides in Varying Degrees of Obesity and Hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Effects of simvastatin versus gemfibrozil on lipids and glucose control in patients with non-insulin-dependent diabetes mellitus. NIDDM Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Simvastatin in non-insulin-dependent diabetes mellitus: effect on serum lipids, lipoproteins and haemostatic measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Comparisons of metabolism of apolipoprotein B in normal subjects, obese patients, and patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Suppression of apolipoprotein B production during treatment of cholesteryl ester storage disease with lovastatin. Implications for regulation of apolipoprotein B synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Kinetic model for production and metabolism of very low density lipoprotein triglycerides. Evidence for a slow production pathway and results for normolipidemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Differences in insulin suppression of free fatty acid levels by gender and glucose tolerance status. Relation to plasma triglyceride and apolipoprotein B concentrations. Insulin Resistance Atherosclerosis Study (IRAS) Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

The role of increased liver triglyceride content: a culprit of diabetic hyperglycaemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Complexity in the secretory pathway: the assembly and secretion of apolipoprotein B-containing lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Regulation of hepatic apolipoprotein B-lipoprotein assembly and secretion by the availability of fatty acids. I. Differential response to the delivery of fatty acids via albumin or remnant-like emulsion particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Contributions of de novo synthesis of fatty acids to total VLDL-triglyceride secretion during prolonged hyperglycemia/hyperinsulinemia in normal man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Measurement of de novo hepatic lipogenesis in humans using stable isotopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Insulin-mediated inhibition of apolipoprotein B secretion requires an intracellular trafficking event and phosphatidylinositol 3-kinase activation: studies with brefeldin A and wortmannin in primary cultures of rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Effect of simvastatin on receptor-dependent low density lipoprotein catabolism in normocholesterolemic human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Apolipoprotein B metabolism in humans: studies with stable isotope-labeled amino acid precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Effects of atorvastatin versus fenofibrate on apoB-100 and apoA-I kinetics in mixed hyperlipidemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Atorvastatin treatment induced peroxisome proliferator-activated receptor alpha expression and decreased plasma nonesterified fatty acids and liver triglyceride in fructose-fed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

Viscount Bledisloe of Lydney, G.C.M.G., K.B.E

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500335-JLR200

10.1194/JLR.M500335-JLR200

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

16162940

1 reference

24 December 2017